SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001628280-24-030318
Filing Date
2024-06-27
Accepted
2024-06-27 16:05:50
Documents
18

Document Format Files

Seq Description Document Type Size
1 424B4 gribio-424b4.htm 424B4 1959828
2 business10aa.jpg GRAPHIC 44408
3 business11aa.jpg GRAPHIC 34482
4 business12aa.jpg GRAPHIC 53120
5 business13aa.jpg GRAPHIC 395414
6 business14aa.jpg GRAPHIC 57447
7 business15aa.jpg GRAPHIC 15021
8 business16aa.jpg GRAPHIC 19551
9 business2aa.jpg GRAPHIC 37056
10 business3aa.jpg GRAPHIC 52730
11 business6aa.jpg GRAPHIC 83695
12 business7aa.jpg GRAPHIC 43990
13 business8aa.jpg GRAPHIC 31742
14 business9aa.jpg GRAPHIC 39199
15 gribiopipelinea.jpg GRAPHIC 199080
16 grilogoa.jpg GRAPHIC 127122
17 nktbyprogressivediseasea.jpg GRAPHIC 126147
18 nktinpatientsa.jpg GRAPHIC 80785
  Complete submission text file 0001628280-24-030318.txt   3946074
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-280323 | Film No.: 241079170
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)